Discover B2B companies, suppliers, and manufacturers related to this keyword category
Clinical-stage biopharmaceutical company developing transformative therapies to treat devastating human diseases
Cellectis is developing life-changing product candidates to target and eradicate cancer cells.
Your Leader in Rare Disease and Complex Therapy Programs
brought to you by Informa Connect
Science fiction becoming science fact.
We're on a mission to make regenerative medicine a part of everyday medicine.
Navigating the Middle East & Africa to Broaden Patient Access, Faster
Personalized T-cell therapies for hematologic malignancies and solid tumors.
Australia & New Zealand's only not-for-profit collaborative blood cancer research group
Your Bridge from ATMPs Concept to Commercialization
Inspired by Nature, driven by data, built for humanity.
Enabling life-saving therapies with a unique technology for cell engineering
Redefining cell therapy manufacturing for the allogeneic future.
Akimbo Bio is developing dual CAR/TCR therapies intended for in vivo delivery via lentiviral vectors.
Your Leader in Rare Disease and Complex Therapy Programs
Market Access Today: Your go-to source for the latest insights, trends, and updates in Market Acces, HEOR, HTA, and RWE.